Investigating the link between sexually transmitted infections and female infertility
Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
University of Luebeck · NCT05244967
This study is trying to see if sexually transmitted infections affect fertility in young women aged 18-22 by looking at their vaginal health over time.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 533 (estimated) |
| Ages | 18 Years to 22 Years |
| Sex | Female |
| Sponsor | University of Luebeck (other) |
| Locations | 1 site (Lübeck) |
| Trial ID | NCT05244967 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the prevalence of sexually transmitted infections (STIs) among young women aged 18-22 and assess how the female genital tract microbiome may influence fertility. Participants will undergo vaginal swab testing to collect data on STIs and microbiome composition. The study will follow a longitudinal approach to gather comprehensive insights over time, focusing on the relationship between STIs and infertility outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are young women aged 18-22 who can provide informed consent.
Not a fit: Patients who are pregnant, sterilized, or unable to give informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of how STIs affect female fertility, leading to better prevention and treatment strategies.
How similar studies have performed: While there have been studies on STIs and fertility, this specific focus on the microbiome's role is relatively novel and may provide new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-22 years * informed consent Exclusion Criteria: * pregnancy * sterilization * not capable of giving informed consent
Where this trial is running
Lübeck
- Klinik für Infektiologie und Mikrobiologie — Lübeck, Germany (RECRUITING)
Study contacts
- Study coordinator: Nadja Käding, Dr.
- Email: nadja.kaeding@uksh.de
- Phone: +4945131019010
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Sexually Transmitted Infection